[{"id":353,"public_id":10,"key":"jpcz0z","name":"Yao_2019_TOX","description":"TOX knock-out vs. WT virus-specific CD8 T cells in chronic infection","ref_id":2,"project_attrs":{"condition":"chronic infection (LCMV Cl13)","tissue":"spleen","timepoints":"day 7 post infection"},"nber_samples":2,"created_at":"2021-08-11T13:05:30.108Z","updated_at":"2026-05-12T17:02:12.343Z","url":"http://spica.unil.ch/projects/353.json"},{"id":358,"public_id":23,"key":"ynt5ce","name":"Ekiz_2019","description":"Effect of miR-155 KO in T cells from melanoma ","ref_id":1,"project_attrs":{"condition":"melanoma (B16)","timepoints":"9-12 days after tumor injection"},"nber_samples":2,"created_at":"2021-08-13T08:56:15.939Z","updated_at":"2026-05-08T22:59:23.940Z","url":"http://spica.unil.ch/projects/358.json"},{"id":338,"public_id":4,"key":"cghndc","name":"Miller_2019","description":"tumor-specific CD8 TILs (tetramer sorted) from B16-OVA tumors","ref_id":1,"project_attrs":{"tissue":"tumor","condition":"melanoma (B16)","timepoints":"10 days post tumor engraftment"},"nber_samples":1,"created_at":"2021-08-11T09:50:51.737Z","updated_at":"2026-05-13T18:18:32.156Z","url":"http://spica.unil.ch/projects/338.json"},{"id":404,"public_id":33,"key":"zmzjea","name":"Andreatta2021_viralCD4","description":"CD4 T cell states across timepoints and type of infection (chronic vs. acute)","ref_id":3,"project_attrs":{"tissue":"Spleen","timepoints":"days 7, 21 and 80 post-infection","condition":"acute and chronic viral infection (LCMV strains Armstrong and Cl13)"},"nber_samples":5,"created_at":"2021-10-01T08:45:51.839Z","updated_at":"2026-05-16T00:30:43.549Z","url":"http://spica.unil.ch/projects/404.json"},{"id":361,"public_id":28,"key":"unsknm","name":"Gubin_2018_myeloid","description":"myeloid APCs infiltrating sarcoma tumors after aPD1 and/or aCTLA4 immunotherapy or in untreated animals","ref_id":4,"project_attrs":{"tissue":"tumor (T3 MCA sarcoma)","condition":"checkpoint blockade"},"nber_samples":4,"created_at":"2021-08-19T08:38:18.487Z","updated_at":"2026-05-15T04:10:21.059Z","url":"http://spica.unil.ch/projects/361.json"},{"id":352,"public_id":7,"key":"povozy","name":"Andreatta_2019","description":"T cells from (MC38) tumor-draining lymph nodes","ref_id":1,"project_attrs":{"tissue":"lymph node","timepoints":"14-19 days post tumor engraftment","condition":"MC38 colon adenocarcinoma"},"nber_samples":1,"created_at":"2021-08-11T12:49:22.961Z","updated_at":"2026-05-04T22:42:04.080Z","url":"http://spica.unil.ch/projects/352.json"},{"id":566,"public_id":36,"key":"gxf773","name":"Ciucci2021_Bcl6-Blimp1_KO","description":"Single-cell gene expression of effector CD4+ T cells WT, Bcl6-deficient , Blimp1-deficient or Bcl6 Blimp1-deficient","ref_id":3,"project_attrs":{"timepoints":"day 7 post infection","tissue":"Spleen","condition":"WT; Bcl6KO; Blimp1KO; DoubleKO"},"nber_samples":4,"created_at":"2021-11-24T09:16:20.727Z","updated_at":"2026-05-14T14:20:38.992Z","url":"http://spica.unil.ch/projects/566.json"},{"id":389,"public_id":30,"key":"sys22n","name":"Bassez_2021_myeloid","description":"MoMacDCs from Responders vs. Non-Responders to ICB in breast cancer patient.","ref_id":4,"project_attrs":{"timepoints":"pre-treatment","tissue":"tumor (breast carcinoma)","condition":"breast carcinoma"},"nber_samples":2,"created_at":"2021-09-29T10:18:00.254Z","updated_at":"2026-05-14T01:32:19.727Z","url":"http://spica.unil.ch/projects/389.json"},{"id":355,"public_id":14,"key":"0tkila","name":"Kanev_2019","description":"CD8 T cells in viral infection: depletion of CD4 T cells vs. Control","ref_id":2,"project_attrs":{"condition":"chronic infection (LCMV Cl13)","tissue":"spleen","timepoints":"40 days post infection"},"nber_samples":2,"created_at":"2021-08-11T13:59:13.081Z","updated_at":"2026-05-08T22:59:00.251Z","url":"http://spica.unil.ch/projects/355.json"},{"id":354,"public_id":12,"key":"sivkyt","name":"Yao_2019_Acute","description":"Acute viral infection, days 4.5 and 7, two replicates per timepoint","ref_id":2,"project_attrs":{"tissue":"spleen","timepoints":"day 4.5 post-infection; day 7 post-infection"},"nber_samples":4,"created_at":"2021-08-11T13:19:09.637Z","updated_at":"2026-05-16T01:28:36.988Z","url":"http://spica.unil.ch/projects/354.json"},{"id":411,"public_id":34,"key":"fk36xo","name":"Khatun_2021","description":"CD4+ T cells at day 10 post-infection with LCMV","ref_id":3,"project_attrs":{"tissue":"spleen","condition":"Acute LCMV infection","timepoints":"day 10 post infection"},"nber_samples":5,"created_at":"2021-10-01T15:38:38.985Z","updated_at":"2026-05-10T13:28:00.527Z","url":"http://spica.unil.ch/projects/411.json"},{"id":351,"public_id":17,"key":"ryyfy0","name":"Bassez_2021","description":"TILs from Responders and Non-Responders to ICB in breast cancer patients.","ref_id":1,"project_attrs":{"timepoints":"pre-treatment","tissue":"tumor (breast carcinoma)","condition":"breast carcinoma"},"nber_samples":2,"created_at":"2021-08-11T12:48:20.768Z","updated_at":"2026-05-14T07:20:58.772Z","url":"http://spica.unil.ch/projects/351.json"},{"id":356,"public_id":16,"key":"edenz4","name":"LaFleur_2019","description":"CD8 T cells in LCMV viral infection; Ptpn2-KO vs WT","ref_id":2,"project_attrs":{"condition":"chronic infection (LCMV Cl13)","tissue":"spleen","timepoints":"30 days post infection"},"nber_samples":2,"created_at":"2021-08-11T14:03:20.265Z","updated_at":"2026-05-08T22:59:43.821Z","url":"http://spica.unil.ch/projects/356.json"},{"id":360,"public_id":26,"key":"uljf21","name":"Gubin_2018","description":"TILs from sarcoma after aPD1 and/or aCTLA4 immunotherapy mouse tumor (T3 MCA sarcoma)","ref_id":1,"project_attrs":{"tissue":"tumor (sarcoma)","timepoints":"11 days after tumor establishment"},"nber_samples":4,"created_at":"2021-08-13T12:12:51.934Z","updated_at":"2026-05-09T22:43:06.920Z","url":"http://spica.unil.ch/projects/360.json"},{"id":337,"public_id":3,"key":"i7e6qx","name":"Sandu_2020","description":"CD8 T cells in chronic viral infection across tissues","ref_id":2,"project_attrs":{"tissue":"multiple","timepoints":"day 21 post infection","condition":"chronic infection (LCMV Cl13)"},"nber_samples":6,"created_at":"2021-08-11T09:09:27.146Z","updated_at":"2026-05-16T01:52:04.655Z","url":"http://spica.unil.ch/projects/337.json"},{"id":362,"public_id":29,"key":"qmmx93","name":"Zilionis_2019_humanAPC","description":"antigen-presenting-cells infiltrating tumors from NSCLC patients","ref_id":4,"project_attrs":{"tissue":"tumor (lung)"},"nber_samples":7,"created_at":"2021-08-19T09:08:00.130Z","updated_at":"2026-05-09T22:43:48.230Z","url":"http://spica.unil.ch/projects/362.json"},{"id":357,"public_id":24,"key":"woz18i","name":"Kunzli_2020","description":"Recovery improvement of virus-specific memory CD4 T cells by treatment with NAD-induced cell death (NICD) protector","ref_id":3,"project_attrs":{"tissue":"spleen","timepoints":"day 30 post infection","condition":"Control vs. NICD-protector treatment in mice following LCMV Arm infection"},"nber_samples":2,"created_at":"2021-08-11T14:05:34.828Z","updated_at":"2026-05-09T22:43:57.962Z","url":"http://spica.unil.ch/projects/357.json"},{"id":348,"public_id":6,"key":"b4s78z","name":"SadeFeldman_2019","description":"TILs from Responders and Non-Responders to ICB in melanoma patients","ref_id":1,"project_attrs":{"tissue":"tumor","timepoints":"pre-treatment","condition":"melanoma"},"nber_samples":2,"created_at":"2021-08-11T12:31:40.307Z","updated_at":"2026-05-14T01:39:24.072Z","url":"http://spica.unil.ch/projects/348.json"},{"id":412,"public_id":35,"key":"yekugo","name":"Ciucci_2019_CD4","description":"Virus-specific CD4+ T cells at day 7 and day 30 post-infection","ref_id":3,"project_attrs":{"tissue":"Spleen","timepoints":"days 7 and 30 post infection","condition":"Acute LCMV infection"},"nber_samples":2,"created_at":"2021-10-01T16:13:24.582Z","updated_at":"2026-05-09T22:16:04.388Z","url":"http://spica.unil.ch/projects/412.json"},{"id":339,"public_id":5,"key":"4vmfqk","name":"Wei_2019","description":"WT vs Regnase KO CD8 TILs (sgRNA transduced OT-I cells)","ref_id":1,"project_attrs":{"tissue":"tumor","condition":"melanoma (B16)","timepoints":"7 days after T cells adoptive transfer"},"nber_samples":4,"created_at":"2021-08-11T10:46:43.156Z","updated_at":"2026-05-12T09:58:19.430Z","url":"http://spica.unil.ch/projects/339.json"},{"id":335,"public_id":2,"key":"mru9ct","name":"Carmona_2019","description":"CD8 TILs from B16 melanoma tumors","ref_id":1,"project_attrs":{"tissue":"tumor","timepoints":"15 day post tumor engraftment","condition":"melanoma (B16)"},"nber_samples":3,"created_at":"2021-08-11T08:36:36.243Z","updated_at":"2026-05-13T02:19:36.188Z","url":"http://spica.unil.ch/projects/335.json"}]